CPXX
Vanguard Group’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,256,026
| Closed | -$37.9M | – | 4156 |
|
|
2016
Q2 | $37.9M | Buy |
1,256,026
+447,203
| +55% | +$13.5M | ﹤0.01% | 2022 |
|
|
2016
Q1 | $8.92M | Buy |
808,823
+272,236
| +51% | +$3M | ﹤0.01% | 2671 |
|
|
2015
Q4 | $945K | Buy |
536,587
+23,353
| +5% | +$41.1K | ﹤0.01% | 3647 |
|
|
2015
Q3 | $852K | Buy |
513,234
+151,643
| +42% | +$252K | ﹤0.01% | 3686 |
|
|
2015
Q2 | $810K | Buy |
361,591
+20,409
| +6% | +$45.7K | ﹤0.01% | 3728 |
|
|
2015
Q1 | $843K | Buy |
341,182
+95,639
| +39% | +$236K | ﹤0.01% | 3681 |
|
|
2014
Q4 | $481K | Buy |
245,543
+21,176
| +9% | +$41.5K | ﹤0.01% | 3741 |
|
|
2014
Q3 | $568K | Hold |
224,367
| – | – | ﹤0.01% | 3681 |
|
|
2014
Q2 | $664K | Buy |
224,367
+34,400
| +18% | +$102K | ﹤0.01% | 3603 |
|
|
2014
Q1 | $614K | Buy |
+189,967
| New | +$614K | ﹤0.01% | 3602 |
|